M A Leal

472 total citations
9 papers, 375 citations indexed

About

M A Leal is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, M A Leal has authored 9 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in M A Leal's work include Antifungal resistance and susceptibility (3 papers), Fungal Infections and Studies (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). M A Leal is often cited by papers focused on Antifungal resistance and susceptibility (3 papers), Fungal Infections and Studies (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). M A Leal collaborates with scholars based in Spain and United States. M A Leal's co-authors include Robert A. Larsen, Madeline Bauer, Donald N. Forthal, Jeremiah G. Tilles, Brenda E. Jones, John M. Leedom, Samuel A. Bozzette, Patricio Aller, John E. Edwards and Robert Lewis and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Experimental Cell Research.

In The Last Decade

M A Leal

9 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M A Leal Spain 8 287 276 35 28 24 9 375
Joy Logan United States 10 201 0.7× 129 0.5× 27 0.8× 11 0.4× 15 0.6× 18 338
R. A. FORSTER United Kingdom 13 131 0.5× 47 0.2× 30 0.9× 18 0.6× 7 0.3× 23 376
Martin E. Winberg Sweden 11 165 0.6× 84 0.3× 103 2.9× 9 0.3× 25 1.0× 16 366
Coad Thomas Dow United States 13 303 1.1× 98 0.4× 120 3.4× 9 0.3× 12 0.5× 25 448
David N. McMurray United States 7 94 0.3× 126 0.5× 69 2.0× 6 0.2× 10 0.4× 8 369
Alexis José-Ábrego Mexico 12 198 0.7× 35 0.1× 34 1.0× 13 0.5× 23 1.0× 27 287
Raquel M. Marques Portugal 12 51 0.2× 90 0.3× 72 2.1× 6 0.2× 14 0.6× 14 387
Beryl Williams Epstein 4 89 0.3× 142 0.5× 51 1.5× 3 0.1× 11 0.5× 6 259
Stephen Stone United States 10 106 0.4× 86 0.3× 161 4.6× 4 0.1× 20 0.8× 17 341
Jyothi F. Nagajyothi United States 10 211 0.7× 52 0.2× 59 1.7× 6 0.2× 7 0.3× 23 279

Countries citing papers authored by M A Leal

Since Specialization
Citations

This map shows the geographic impact of M A Leal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M A Leal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M A Leal more than expected).

Fields of papers citing papers by M A Leal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M A Leal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M A Leal. The network helps show where M A Leal may publish in the future.

Co-authorship network of co-authors of M A Leal

This figure shows the co-authorship network connecting the top 25 collaborators of M A Leal. A scholar is included among the top collaborators of M A Leal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M A Leal. M A Leal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Bauer, Madeline, M A Leal, Debra Johnson, et al.. (1997). Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis. Antimicrobial Agents and Chemotherapy. 41(7). 1589–1593. 48 indexed citations
2.
Leal, M A, Patricio Aller, & C. Calle. (1996). Effect of dexamethasone on insulin receptor mRNA levels, RNA stability and isotype RNA pattern in U-937 human promonocytic cells. Journal of Endocrinological Investigation. 19(8). 530–534. 9 indexed citations
3.
Witt, Mallory D., Robert Lewis, Robert A. Larsen, et al.. (1996). Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis Who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility Testing. Clinical Infectious Diseases. 22(2). 322–328. 112 indexed citations
4.
Sáez, Rosana, et al.. (1996). Synergism between two growth regulatory pathways: cooperative transformation of NIH3T3 cells by G alpha 12 and c-raf-1.. PubMed. 12(11). 2377–83. 7 indexed citations
5.
Leal, M A, Patricio Aller, Antonio Más, & Consuelo Calle. (1995). The Effect of 1,25-Dihydroxyvitamin D3 on Insulin Binding, Insulin Receptor mRNA Levels, and Isotype RNA Pattern in U-937 Human Promonocytic Cells. Experimental Cell Research. 217(2). 189–194. 25 indexed citations
6.
Larsen, Robert A., Samuel A. Bozzette, Brenda E. Jones, et al.. (1994). Fluconazole Combined with Flucytosine for Treatment of Cryptococcal Meningitis in Patients with AIDS. Clinical Infectious Diseases. 19(4). 741–745. 147 indexed citations
7.
Leal, M A, et al.. (1994). Tissue-Specific Changes in Insulin Receptor mRNA Concentrations in Dexamethasone-Treated and Adrenalectomized Rats.. Endocrine Journal. 41(6). 737–741. 10 indexed citations
8.
Leal, M A, et al.. (1993). Tissue‐specific modulation of insulin receptor mRNA levels in a patient with a phaeochromocytoma. Clinical Endocrinology. 39(5). 619–621. 2 indexed citations
9.
Leal, M A, Carlos Cabañas, Carlos Rı́us, Patricio Aller, & C. Calle. (1992). Modulation by dexamethasone of insulin binding and insulin receptor mRNA levels in U-937 human promonocytic cells. Biochimie. 74(6). 545–549. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026